Weekly insight and inspiration to grow your community pharmacy practice

In this episode, we describe the latest information concerning hypercoagulability with COVID-19 infection.  Emerging evidence suggests that patients with COVID infection may be hypercoagulable and prone to clotting. Listen in as we discuss the evidence surrounding this issue and how to address therapeutic issues in anticoagulation in this population.


This episode is accredited for CPE.  For CE details and to claim credit go to

©2019 CEImpact

  • Grey LinkedIn Icon
  • Grey Facebook Icon
  • Grey Instagram Icon
  • Grey Twitter Icon